Zentalis Pharmaceuticals ...

NASDAQ: ZNTL · Real-Time Price · USD
1.61
0.13 (8.78%)
At close: Aug 15, 2025, 3:08 PM

Zentalis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-165.87M -292.19M -237.11M -166.09M
Depreciation & Amortization
1.29M 1.39M 1.43M 544K
Stock-Based Compensation
67.27M 54.82M 46.84M 35.74M
Other Working Capital
6.48M -5.05M -2.27M 2.23M
Other Non-Cash Items
-57.01M 23.15M 12.61M -38.38M
Deferred Income Tax
n/a -853K -769K -2.46M
Change in Working Capital
-16.54M 5.86M 13.25M 16.56M
Operating Cash Flow
-170.86M -207.82M -163.75M -154.09M
Capital Expenditures
-221K -583K -2.55M -6.11M
Cash Acquisitions
65K n/a 111.63K -14.32M
Purchase of Investments
-127.96M -549.18M -533.16M -363.51M
Sales Maturities Of Investments
304.68M 505.31M 421.53M 365.82M
Other Investing Acitivies
n/a n/a -111.63K n/a
Investing Cash Flow
176.56M -44.46M -114.18M -18.11M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-241K n/a n/a -1.15M
Financial Cash Flow
108K 237.3M 261.04M 178.52M
Net Cash Flow
5.81M -14.98M -16.89M 6.31M
Free Cash Flow
-171.08M -208.41M -166.3M -160.2M